Clinicial contract research organisation Accutest Biologics on Monday said it has received Organisation for Economic Co-operation and Development (OECD)-Good Laboratory Practice (GLP) certification for the next three years.
National Good Laboratory Practice Compliance Monitoring Authority (NGCMA) had conducted a detailed pre-inspection of the test facility located at Navi Mumbai, Accutest Biologics said in a statement.
"The Navi Mumbai facility is capable of conducting toxicity studies, mutagenicity studies, analytical and clinical testing," Accutest Biologics Pvt Ltd Founder and CEO Satish Sawant said.
This significant milestone enables the company to advance as the global service provider, he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
